Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 346

Results For "IMI"

3545 News Found

Shilpa Medicare to produce 50 mn doses of Sputnik V Vaccine
News | May 18, 2021

Shilpa Medicare to produce 50 mn doses of Sputnik V Vaccine

Targeted production of the dual vector Sputnik V for the first 12 months is 50 million doses from the date of start of commercial production


Outlook promising for Cipla: HDFC Securities
News | May 18, 2021

Outlook promising for Cipla: HDFC Securities

The outlook for the US business remains good as respiratory pipeline (gAbraxane, gAdvair, gDulera) adds medium-term growth visibility.


Sputnik V launch to lift near-term outlook for Dr. Reddy's Labs: HDFC Securities
News | May 18, 2021

Sputnik V launch to lift near-term outlook for Dr. Reddy's Labs: HDFC Securities

Dr. Reddy's has the rights to distribute 250mn doses in India


Outlook intact for Dr. Reddy's Laboratories : ICICI Securities
News | May 18, 2021

Outlook intact for Dr. Reddy's Laboratories : ICICI Securities

India sales grew 23.5% YoY with consolidation of Wockhardt products


Cadila Healthcare divests animal health business: ICICI Securities
News | May 16, 2021

Cadila Healthcare divests animal health business: ICICI Securities

The company plans to aggressively invest in longer gestation period projects like innovation, biosimilars, vaccines, etc.


Govt. to supply 1.92 crore COVID vaccines during May 16-31
News | May 16, 2021

Govt. to supply 1.92 crore COVID vaccines during May 16-31

A total quantum of more than 4.39 crore doses was also available for direct procurement by the states as well as private hospitals in the month of May 2021


Govt. to augment Covaxin production by 10 crore doses
News | May 16, 2021

Govt. to augment Covaxin production by 10 crore doses

Financial support is being provided as a grant from the Government of India


SPARC announces positive results from Phase 3 trial of PDP-716
News | May 15, 2021

SPARC announces positive results from Phase 3 trial of PDP-716

The trial met its pre-specified primary endpoint, demonstrating that PDP-716 dosed once daily is equivalent to Alphagan P 0.1% dosed 3 times a day


Alembic gets USFDA approval for Lurasidone Hydrochloride tablets
News | May 15, 2021

Alembic gets USFDA approval for Lurasidone Hydrochloride tablets

Lurasidone Hydrochloride tablets are also indicated for adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar I disorder


Dr. Reddy's Sputnik V India price is Rs. 995.40
News | May 15, 2021

Dr. Reddy's Sputnik V India price is Rs. 995.40

The company is working closely with its six manufacturing partners in India